Glaucoma is the first leading cause of irreversible blindness worldwide with increasing importance in public health.Indicators of glaucoma care quality as well as efficiency would benefit public health assessments,but...Glaucoma is the first leading cause of irreversible blindness worldwide with increasing importance in public health.Indicators of glaucoma care quality as well as efficiency would benefit public health assessments,but are lacking.We propose three such indicators.First,the glaucoma coverage rate(GCR),which is the number of people known to have glaucoma divided by the total number of people with glaucoma as estimated from population-based studies multiplied by 100%.Second,the glaucoma detection rate(GDR),which is number of newly diagnosed glaucoma patients in one year divided by the population in a defined area in millions.Third,the glaucoma follow-up adherence rate(GFAR),calculated as the number of patients with glaucoma who visit eye care provider(s)at least once a year over the total number of patients with glaucoma in given eye care provider(s)in a specific period.Regularly tracking and reporting these three indicators may help to improve the healthcare system performance at national or regional levels.展开更多
目的了解中国大陆地区2006—2016年高血压患者的服药依从率,为制定合适的公共卫生政策以提高高血压患者的服药依从率提供参考依据。方法检索中国知网数据库、万方数据库、维普中国科技期刊数据库和PubMed数据库,并辅以文献追溯法收集200...目的了解中国大陆地区2006—2016年高血压患者的服药依从率,为制定合适的公共卫生政策以提高高血压患者的服药依从率提供参考依据。方法检索中国知网数据库、万方数据库、维普中国科技期刊数据库和PubMed数据库,并辅以文献追溯法收集2006年1月1日—2016年12月31日公开发表的关于中国大陆地区高血压患者服药依从率的相关文献,应用Stata 12.0软件对纳入的文献进行meta分析。结果最终纳入19篇中文文献,累计研究对象44 322例。meta分析结果显示,中国大陆地区高血压患者服药依从率为42.5%(95%CI=37.4%~47.6%)。亚组分析结果显示,城市高血压患者的服药依从率为44.5%,高于农村高血压患者的38.9%,差异有统计学意义(χ~2=57.254,P <0.001);东北部、东部、中西部高血压患者的服药依从率分别为36.9%、40.6%、47.9%,差异有统计学意义(χ~2=316.846,P <0.001);发表年份在2006—2011年文献中高血压患者的服药依从率为37.5%,低于发表年份在2012—2016年文献中的45.3%,差异有统计学意义(χ~2=68.852, P <0.001);高质量文献中高血压患者的服药依从率为40.5%,低于中低质量文献中的50.8%(χ~2=33.095, P <0.001)。Begg′s检验和Egger′s检验结果均显示本次纳入meta分析的文献不存在发表偏倚(均P> 0.05)。结论中国大陆地区高血压患者服药依从性较差,应深入研究影响高血压患者服药依从性的因素,以利于相关部门采取更有针对性的干预措施提高患者的服药依从率。展开更多
基金funded by Wenzhou Medical University R&D Fund,No.QTJ13009Health Innovation Talents in Zhejiang Province(2016).No.25.
文摘Glaucoma is the first leading cause of irreversible blindness worldwide with increasing importance in public health.Indicators of glaucoma care quality as well as efficiency would benefit public health assessments,but are lacking.We propose three such indicators.First,the glaucoma coverage rate(GCR),which is the number of people known to have glaucoma divided by the total number of people with glaucoma as estimated from population-based studies multiplied by 100%.Second,the glaucoma detection rate(GDR),which is number of newly diagnosed glaucoma patients in one year divided by the population in a defined area in millions.Third,the glaucoma follow-up adherence rate(GFAR),calculated as the number of patients with glaucoma who visit eye care provider(s)at least once a year over the total number of patients with glaucoma in given eye care provider(s)in a specific period.Regularly tracking and reporting these three indicators may help to improve the healthcare system performance at national or regional levels.
文摘目的了解中国大陆地区2006—2016年高血压患者的服药依从率,为制定合适的公共卫生政策以提高高血压患者的服药依从率提供参考依据。方法检索中国知网数据库、万方数据库、维普中国科技期刊数据库和PubMed数据库,并辅以文献追溯法收集2006年1月1日—2016年12月31日公开发表的关于中国大陆地区高血压患者服药依从率的相关文献,应用Stata 12.0软件对纳入的文献进行meta分析。结果最终纳入19篇中文文献,累计研究对象44 322例。meta分析结果显示,中国大陆地区高血压患者服药依从率为42.5%(95%CI=37.4%~47.6%)。亚组分析结果显示,城市高血压患者的服药依从率为44.5%,高于农村高血压患者的38.9%,差异有统计学意义(χ~2=57.254,P <0.001);东北部、东部、中西部高血压患者的服药依从率分别为36.9%、40.6%、47.9%,差异有统计学意义(χ~2=316.846,P <0.001);发表年份在2006—2011年文献中高血压患者的服药依从率为37.5%,低于发表年份在2012—2016年文献中的45.3%,差异有统计学意义(χ~2=68.852, P <0.001);高质量文献中高血压患者的服药依从率为40.5%,低于中低质量文献中的50.8%(χ~2=33.095, P <0.001)。Begg′s检验和Egger′s检验结果均显示本次纳入meta分析的文献不存在发表偏倚(均P> 0.05)。结论中国大陆地区高血压患者服药依从性较差,应深入研究影响高血压患者服药依从性的因素,以利于相关部门采取更有针对性的干预措施提高患者的服药依从率。
